ACADIAN ASSET MANAGEMENT LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 916542 Boston, MA

Position in FULC

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,578,506

-$2,754,023 QoQ

Shares Held

727,315

-1.3% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#26

of 168 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. FULC ranks #22 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,578,506	727,315	-1.3%	Shares	Defined	2026-05-13
2025-12-31	$8,332,529	736,740	+36.3%	Shares	Defined	2026-02-10
2025-09-30	$4,973,897	540,641	-4.0%	Shares	Defined	2025-11-13
2025-06-30	$3,876,054	563,380	+63.5%	Shares	Defined	2025-08-07
2025-03-31	$992,335	344,561	+865.0%	Shares	Defined	2025-05-21
2024-12-31	$167,822	35,707	-81.1%	Shares	Defined	2025-02-11
2024-09-30	$674,590	188,961	+5344.0%	Shares	Defined	2024-11-12
2021-03-31	$40,888	3,471	+84.5%	Shares	Defined	2021-05-11
2020-09-30	$14,916	1,881	—	Shares	Defined	2020-11-09
No filing history on record for this holder in this stock.